Evidence map›Paper›PMID 36381912›Full record

ArticleCureus2022

IgA Vasculitis With Adalimumab Therapy for Hidradenitis Suppurativa: A Case Report and Review of Literature.

Sarah Alsulami, Rakan M Alotaibi, Faisal F Alotaibi, Faisal B Almatrafi, Doaa M Filmban, Sultan Alneefia, AhmedHusam Alahmed, Waleed A Hafiz

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sarah AlsulamiDepartment of Medicine, Al Noor Specialist Hospital, Makkah, SAU.
Rakan M AlotaibiDepartment of Medicine, College of Medicine, Umm Al-Qura University, Makkah, SAU.
Faisal F AlotaibiDepartment of Medicine, College of Medicine, Umm Al-Qura University, Makkah, SAU.
Faisal B AlmatrafiDepartment of Medicine, College of Medicine, Umm Al-Qura University, Makkah, SAU.
Doaa M FilmbanDepartment of Medicine, Al Noor Specialist Hospital, Makkah, SAU.
Sultan AlneefiaDepartment of Medicine, College of Medicine, Umm Al-Qura University, Makkah, SAU.
AhmedHusam AlahmedDepartment of Medicine, Al Noor Specialist Hospital, Makkah, SAU.
Waleed A HafizDepartment of Medicine, College of Medicine, Umm Al-Qura University, Makkah, SAU.
Al Noor Hospitals · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulin A (IgA) vasculitis is a systemic vasculitis characterized by inflammation of the small vessels, with cutaneous, musculoskeletal, gastrointestinal, and renal involvement, usually seen in pediatric populations. Hidradenitis suppurativa is a chronic inflammatory disorder of the skin, which can be treated by tumor necrosis factor-α (TNFα) inhibitor therapy. TNFα inhibitor therapy is used as an important milestone in the treatment of various rheumatological and autoimmune disorders. Unexpected adverse effects might occur. However, they are usually mild and do not warrant treatment withdrawal. We present a case of IgA vasculitis complicating adalimumab therapy for hidradenitis suppurativa. We also review and discuss similar cases reported in the literature.

Indexed as

adalimumabadult iga vasculitisanti-tnf agentsanti-tnf alphadermatologyhenoch schönlein purpurahidradenitis suppurativarheumatologyvasculitis

Identifiers

PMID36381912
PMCPMC9644201
OpenAlexW4304145135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.